Journal of managed care & specialty pharmacy

J Manag Care Spec Pharm · ISSN (e) 2376-1032 · 16 papers in corpus
2025
2024
2023
2023
doi:10.18553/jmcp.2023.29.2.197 ·PMID:36705286

BACKGROUND: Migraine is the second most common cause of disability worldwide. Understanding the relationship between migraine and employment status is critical for policymakers, as disability-related unemployment is associated with eligibil…

2021
doi:10.18553/jmcp.2021.20471 ·PMID:33779245

BACKGROUND: U.S. value framework developers such as the Institute for Clinical and Economic Review (ICER) use cost-effectiveness analysis to value new health care technologies. Often, these value assessment frameworks use a health system pe…

2020
doi:10.18553/jmcp.2020.26.1-a.s2 ·PMID:31958025

BackgroundUterine fibroids (UF) affect up to 70%-80% of women by 50 years of age and represent a substantial economic burden on patients and society. Despite the high costs associated with UF, recent studies on the costs of UF-related surgi…

2020
doi:10.18553/jmcp.2020.26.8.962 ·PMID:32715961

BackgroundOvarian cancer is the tenth most common type of cancer and the fifth leading cause of cancer death among females in the United States. The majority of incident ovarian cancer cases are diagnosed in individuals aged < 65 years, but…

2020
doi:10.18553/jmcp.2020.26.4-a.s1 ·PMID:32293214

The abstracts presented in this program were originally slated to be presented at the AMCP 2020 meeting in Houston, Texas, April 21-24. The meeting was canceled because of the COVID-19 crisis. In lieu of the scheduled poster presentations, …

2020
doi:10.18553/jmcp.2020.26.12.1590 ·PMID:33251999

BACKGROUND: There has been growing interest in using real-world evidence (RWE) for health technology assessment (HTA) in the United States. The Institute for Clinical and Economic Review (ICER) is an independent U.S.-based HTA organization …

2020
doi:10.18553/jmcp.2020.26.5.652 ·PMID:32347177

BackgroundValue assessment reports are increasingly being considered in health care coverage decisions. The inputs included and analytic methodologies underlying these reports should include all components of value.ObjectiveTo determine whe…

2019
doi:10.18553/jmcp.2019.25.5.521 ·PMID:31039064

There is currently a movement to make economic models more transparent, with some arguing for completely open-source models. However, increasing model transparency raises several logistical challenges, including ownership and funding. This …

article 2019
doi:10.18553/jmcp.2019.25.5.566 ·PMID:31039061

BACKGROUND: Endometriosis is a painful chronic inflammatory disease caused by endometrial tissue implanting and growing outside the uterus, resulting in pelvic pain symptoms and subfertility. Treatment imposes a substantial economic burden …

2018
doi:10.18553/jmcp.2018.24.10-a.s1 ·PMID:30295118

AMCP Nexus 2018: Preparing for the Next Generation of Care in Orlando, Florida, is expected to attract more than 2,400 managed care pharmacists and other health care professionals who manage and evaluate drug therapies, develop and manage n…

2018
article 2017
doi:10.18553/jmcp.2017.23.7.745 ·PMID:28650252

BACKGROUND: Characterized by pain symptoms, endometriosis affects women's productivity in their prime working years. OBJECTIVE: To evaluate the effect of individual endometriosis symptoms on household chore and employment productivity as me…

other 2016
doi:10.18553/jmcp.2016.22.5.573 ·PMID:27123918

BACKGROUND: Endometriosis affects over 10 million women in the United States. Depot leuprolide acetate (LA), a gonadotropin-releasing hormone agonist, has been used extensively for the treatment of women with endometriosis but is associated…